Goals

  • Develop and continuously update technical expertise to analyse cellular adaptive immunity and update, develop and standardize tools and computational analyses and modelling of the data across disease fields.
  • Leverage these tools and gain knowledge to develop new or improved diagnostic tests and treatments.
  • Increase our knowledge into the biology of the adaptive immune system in health and disease.
  • Obtain collaborative grants to initiate new collaborations and continue existing ones. Funding opportunities will be exploited both from national and international sources (EU, US NIH) and from public and private sources.
  • Structurally participate in educational tracks, initially of master student courses. Develop educational/instructive/interactive multimedia content in collaboration with patient associations that explains the role of our adaptive immune cells in diseases, like autoreactive T/B cells in Sjogren and systemic sclerosis or boosting immunity by vaccines.


go to main content
Research Research programs Cellular adaptive immunity 

Our purpose

We aim to develop and continuously update technical expertise to analyse cellular adaptive immunity and update, develop and standardize tools and computational analyses and modelling of the data across disease fields.

Goals

See some of the most important goals for this research program.

read more

Research groups contributing to this research program

Comparative genomics

Martijn Huijnen's research group is a computational research group that develops methods to analyse 'omics types of data and that applies those methods on specific biomedical research questions, like the function of disease genes and identifying cell types associated with disease, 

Computational immunology

Johannes Textor's research group studies the adaptive immune system, and its response to cancer, using computational tools such as simulations, machine learning algorithms, and artificial intelligence.

Experimental immunology

Annemiek van Spriel's research group studies the immune system at the cellular and molecular level. 

Spokesperson

prof. dr. Martijn Huijnen

contact form